Skip to main content

​GATC Biotech expands its sequencing laboratories in Constance and Cologne

News   •   Nov 10, 2011 06:48 GMT

30 new jobs are planned in 2012

Europe’s leading sequencing service provider GATC Biotech continues to grow in 2012. The company will expand the laboratories at its headquarters in Constance and plans to establish a new site in Cologne, Germany.

The premises in Constance will become the new European Genome and Diagnostics Center with GATC Biotech’s fleet of Next and Third Generation sequencing systems, such as Illumina HiSeq 2000 and Pacific Biosciences PacBio RS. There the company will focus on genome sequencing projects, offering its customers true multiplatform sequencing strategies. Furthermore, the laboratories of the daughter company LifeCodexx will be extended to provide the necessary capacity for the upcoming non-invasive molecular genetic prenatal diagnostic test for trisomy 21.

The new laboratory in Cologne will concentrate on single sample sequencing due to its central location in Europe and its excellent infrastructure. With the improved logistics and closeness to customers the company will be able to offer shortest delivery times and highly competitive prices.

GATC Biotech will therefore create more than 30 new jobs in in the coming year for both sites and grow to a total of 170 employees. Thus, the company’s workforce will have more than quadrupled since 2006.

“Rapidly developing new technologies and high price pressure are the key market drivers in our business. With our clear focus and strategy of consolidation we will meet the new challenges successfully. I would like to express my gratitude to all our employees who are actively supporting the decisions and drive them forward with highly motivated spirit,” says Peter Pohl, CEO of GATC Biotech and Chairman of the Supervisory Board of LifeCodexx AG.

Press contact:

Elke Decker
GATC Biotech AG
Director Strategic Marketing & Corp Comm
e.decker@gatc-biotech.com

Comments (0)

Add comment

Comment